|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Emergence of a new antibiotic resistance mechanism in India,Pakistan,and the UK:a molecular,biological,and epidemiological study显示文摘 | WOODFORD N KUMARASAMY K K TOLEMAN M A | | Lancet Infectious Diseases0，，： | 2 |
| 2 | Prevalence and incidence of swxually transmitted infections among South Indians at increased risk of HIV infection显示文摘 | Kumarasamy N Balakrishnan P Venkatesh KK | 2008 | AIDS Patient Care STDS2008，22，8： | 1 |
| 3 | Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study 显示文摘 | Kumarasamy KK Toleman MA Walsh TR Bagaria J Butt F Balakrishnan R Chaudhary U Doumith M Giske CG Irfan S Krishnan P Kumar AV Maharjan S Mushtaq S Noorie T Paterson DL Pearson A Perry C Pike R Rao B Ray U Sarma JB Sharma M Sheridan E Thirunarayan MA Turton J Upadhyay S Warner M Welfare W Livermore DM Woodford N | 2010 | Lancet Infect Dis2010，10，9： | 1 |
| 4 | Risk factors for HIV transmission among heterosexual discordant couples in south India 显示文摘 | Kumarasamy N Venkatesh KK Srikrishnan AK | 2010 | HIV Med2010，11，3： | 1 |
| 5 | Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India显示文摘 | Kumarasamy N Venkatesh KK Devaleenol B | 2010 | Int J Infect Dis2010，14，2： | 1 |
| 6 | Total lymphocyte count(TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource- constrained countries 显示文摘 | Kumarasamy N Mahajan AP Flanigan TP | 2002 | J Acqnir Immune Defic Syndr2002，31，4： | 1 |
| 7 | Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries显示文摘 | Kumarasamy N Mahajan AP Flanigan TP | 2002 | J Acquire Immune Defic Syndr2002，31，： | 1 |
| 8 | Total lym- phocyte count (TCL) is a useful tool for the timing of oppor- tunistic infection prophylaxix in India and other resource con- strained countrise 显示文摘 | Kumarasamy N MahajanAP Flanigan TP | 2002 | Acquired Immunodefieiency Syn- drome2002，31，： | 1 |
| 9 | Deteetion of pulmonary Mycoplasma pneumonia infections in HIV-infected subjectsusing culture and serology显示文摘 | Shankar E M Kumarasamy N Balakrishnan P | 2007 | Int J Infect Dis2007，11，3： | 1 |
| 10 | Evidence of oxidative stress in the circulation of ovarian cancer patients显示文摘 | Kumarasamy S Selvaraj A Namasivayam N | 2004 | Clinica Chimica Acta2004，339，1： | 1 |
| 11 | Retroperitoneal sarcomas 显示文摘 | Kumarasamy N A Gayer G | 2011 | Semi-nars in ultrasound CT and MR2011，32，5： | 1 |
| 12 | Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constralned countries 显示文摘 | Kumarasamy N Mahajan AP Flanigan TP | 2002 | Acquir Immune Defic Syndr2002，31，： | 1 |
| 13 | The social impact of HIV/AIDS in India显示文摘 | Solomon S Kumarasamy N Challacombe S J | 2016 | Oral Dis2016，22，18： | 1 |
| 14 | Ritonavir-boosted lopi- navir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first- line HAART regimen (SECOND-LINE) : a randomised, open-label, non-inferiority study 显示文摘 | Boyd MA Kumarasamy N Moore CL | 2013 | Lancet2013，，9883： | 1 |
| 15 | Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries显示文摘 | Kumarasamy N Mahajan AP Flanigan TP | 2002 | Acquir Immune Defic Syndr2002，31，： | 1 |
| 16 | Incidence ofimmune constitution syndrome in HIV/tuberculosis-coinfectedpatients after initiation of generic antiretroviral therapy in India显示文摘 | N Kumarasamy Sreekanth C Kenneth H | 2004 | J Acquir Immune Defic Syndr2004，37，5： | 1 |
| 17 | Confection of hepatitis B and hepatitis C virus in HIV-infected patients in south India 显示文摘 | Saravanan S Velu V Kumarasamy N | 2007 | World J Gastroenterol2007，13，： | 1 |
| 18 | Safe ty, tolerability, and efficacy of second-line generic protease inhibitor containing HAART after first-line failure among south indian HIV-infected patients显示文摘 | Kumarasamy N Venkatesh KK Devaleenal B | 2011 | J Int Assoc Physi- cians AIDS Care2011，10，2： | 1 |
| 19 | Dermatologic manifestations among human immunodeficiency virus patients in south India显示文摘 | Kumarasamy N Solomon S Madhivanan P | 2000 | Int J Dermatol2000，39，3： | 1 |
| 20 | Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodefieiency virus/acquired immune deficiency syndrome 显示文摘 | Venkatesh KK Biswas J Kumarasamy N | 2008 | Indian J Ophthalmo12008，5，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员